Search

Search Results
Results 671 - 680 of 705 for Depression
  • Kozenis
    Drug - 25 Mar 2022
    Consumer Medicine Information (CMI) about Kozenis intended for persons living in Australia.
  • Zanidip
    Drug - 13 Mar 2022
    Consumer Medicine Information (CMI) about Zanidip intended for persons living in Australia.
  • Invega Hafyera
    Drug - 23 Feb 2022
    Consumer Medicine Information (CMI) about Invega Hafyera intended for persons living in Australia.
  • Lorviqua
    Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Lorviqua intended for persons living in Australia.
  • Metomax
    Drug - 10 Dec 2021
    Consumer Medicine Information (CMI) about Metomax (paracetamol & metoclopramide hydrochloride) intended for persons living in Australia.
  • Hysone
    Drug - 28 Nov 2021
    Consumer Medicine Information (CMI) about Hysone intended for persons living in Australia.
  • DBL Atracurium Besilate
    Drug - 18 Oct 2021
    Consumer Medicine Information (CMI) about DBL Atracurium Besilate (Atracurium besilate) intended for persons living in Australia.
  • Hygroton 25
    Drug - 20 Sep 2021
    Consumer Medicine Information (CMI) about Hygroton 25 (Chlortalidone) intended for persons living in Australia.
  • Vesicare
    Drug - 9 Sep 2021
    Consumer Medicine Information (CMI) about Vesicare intended for persons living in Australia.
  • Betmiga
    Drug - 21 Jul 2021
    Consumer Medicine Information (CMI) about Betmiga intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback